CAST and cardiac hypertrophy: It has been reported that transgenic over-expression of CAST significantly attenuated angiotensin II-induced myocardial hypertrophy [7], diabetes-related myocardial hypertrophy and fibrosis [8] and endotoxaemia-induced myocardial dysfunction [9].